omeprazole

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, and gastroesophageal reflux disease. It is also used for the eradication of Helicobacter pylori and in Zollinger-Ellison syndrome.

Form: lyophilisate for solution for injection

ATC: A02BC01

Manufacturer: Napro Life Sciences Pvt. Ltd.

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, gastroesophageal reflux disease, as well as for the eradication of H. pylori bacteria in combination with antibiotics. It is also used for Zollinger–Ellison syndrome and for the prevention of ulcers caused by the use of anti-inflammatory drugs (NSAIDs).

Form: powder for injection solution

ATC: A02BC01

Manufacturer: Reyoung Pharmaceutical Co., Ltd.

The drug is used for the symptomatic treatment of rheumatoid arthritis and osteoarthritis in adults who are at risk of developing gastric or duodenal ulcers due to the use of anti-inflammatory agents.

Form: capsules, modified release, hard

ATC: M01AB55

Manufacturer: Swiss Caps GmbH (Responsible for batch release, primary and secondary packaging)

The drug is used to treat functional dyspepsia, reflux esophagitis, gastroparesis, and conditions where stomach contents evacuate too slowly.

Form: capsules

ATC: A02

Manufacturer: Intervetia Helskeia Ltd

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, and gastroesophageal reflux disease. It is also used for the eradication of H. pylori bacteria in combination with antibiotics and in Zollinger-Ellison syndrome.

Form: powder for injection solution

ATC: A02BC01

Manufacturer: DEMO S.A. Pharmaceutical Industry

The drug is used for the treatment of gastric and duodenal ulcers, prevention of their recurrence, treatment of reflux esophagitis, and gastroesophageal reflux disease. It is also used for the eradication of Helicobacter pylori (in combination with antibiotics) and in Zollinger–Ellison syndrome.

Form: capsules

ATC: A02BC01

Manufacturer: PJSC "Kyivmedpreparat"

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis and gastroesophageal reflux disease. It is also used for the eradication of Helicobacter pylori in combination with antibiotics and in Zollinger-Ellison syndrome.

Form: lyophilisate for solution for injection

ATC: A02BC01

Manufacturer: Napro Life Sciences Pvt. Ltd

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis and gastroesophageal reflux disease. It is also used for the eradication of Helicobacter pylori in combination with antibiotics and in Zollinger-Ellison syndrome.

Form: powder for solution for infusion

ATC: A02BC01

Manufacturer: Farmex Group LLC

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis (GERD), as well as for the eradication of H. pylori bacteria (as part of combination therapy with antibiotics).

Form: capsules, hard enteric-coated

ATC: A02BC01

Manufacturer: Laboratorios Liconsa, S.A. (manufacturing, primary and secondary packaging, quality control and batch release)

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. It is also used for the eradication of H. pylori bacteria in combination with antibiotics.

Form: powder for injection solution

ATC: A02BC01

Manufacturer: Shandong Yuxing Pharmaceutical Co., Ltd.

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, symptomatic gastroesophageal reflux disease, and Zollinger-Ellison syndrome. It is also used for the eradication of Helicobacter pylori in combination with antibiotics.

Form: capsules

ATC: A02BC01

Manufacturer: Farmak JSC

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, and symptomatic gastroesophageal reflux disease. It is also used for the eradication of Helicobacter pylori in combination with antibiotics and in Zollinger-Ellison syndrome.

Form: capsules

ATC: A02BC01

Manufacturer: Farmak JSC

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, symptomatic gastroesophageal reflux disease, and Zollinger-Ellison syndrome. It is also used for the eradication of H. pylori bacteria in combination with antibiotics.

Form: capsules

ATC: A02BC01

Manufacturer: Farmak JSC

The drug is used to treat gastric and duodenal ulcers, gastroesophageal reflux disease, Zollinger-Ellison syndrome, and to reduce the symptoms of acid-related dyspepsia. It is also used for the eradication of Helicobacter pylori bacteria (as part of combination therapy) and for the prevention of gastric acid aspiration.

Form: capsules

ATC: A02BC01

Manufacturer: ASTRAFARM LLC

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis (GERD), the eradication of H. pylori bacteria (in combination with antibiotics), as well as for the treatment of Zollinger–Ellison syndrome.

Form: capsules, hard gastro-resistant

ATC: A02BC01

Manufacturer: Teva Pharma S.L.U.

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori in combination with antibiotics.

Form: capsules

ATC: A02BC01

Manufacturer: Flamingo Pharmaceuticals Ltd.

The drug is used for the treatment and prevention of gastric and duodenal ulcers (including those caused by anti-inflammatory drugs), for the eradication of H. pylori bacteria, for the treatment of gastroesophageal reflux disease (reflux esophagitis), and Zollinger–Ellison syndrome.

Form: capsules, modified release

ATC: A02BC01

Manufacturer: Artura Pharmaceuticals Pvt. Ltd.

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, Zollinger-Ellison syndrome, as well as for the eradication of H. pylori bacteria in combination with antibiotics.

Form: powder for injection solution

ATC: A02BC01

Manufacturer: ASTRAFARM LLC (packaging from bulk: Shandong Yuxing Pharmaceutical Co., Ltd., People's Republic of China)

The drug is used for the treatment and prevention of gastric and duodenal ulcers (including those caused by anti-inflammatory drugs), the treatment of gastroesophageal reflux disease (reflux esophagitis), the eradication of H. pylori bacteria in combination with antibiotics, and for the treatment of Zollinger-Ellison syndrome.

Form: capsules

ATC: A02BC01

Manufacturer: KRKA, d.d., Novo mesto

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. It is also used for the eradication of Helicobacter pylori in combination with antibiotics.

Form: powder for solution for infusion

ATC: A02BC01

Manufacturer: Abhil Laboratories Private Limited

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, and gastroesophageal reflux disease. It is also used for the eradication of H. pylori bacteria in combination with antibiotics and for Zollinger-Ellison syndrome.

Form: powder for solution for infusion

ATC: A02BC01

Manufacturer: Laboratorios Normon S.A.

The drug is used to treat gastric and duodenal ulcers, gastroesophageal reflux disease, Zollinger-Ellison syndrome, and to reduce dyspepsia symptoms. It is also used for the eradication of Helicobacter pylori bacteria (as part of combination therapy) and for the prevention of gastric acid aspiration.

Form: capsules

ATC: A02BC01

Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, and gastroesophageal reflux disease. It is also used for the eradication of Helicobacter pylori in combination with antibiotics and for Zollinger-Ellison syndrome.

Form: powder for solution for infusion

ATC: A02BC01

Manufacturer: JSC "Farmak" (manufacturing of bulk products from manufacturer Laboratorios Normon S.A., Spain)

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis (GERD), the eradication of H. pylori bacteria (in combination with antibiotics), as well as for the treatment of Zollinger–Ellison syndrome.

Form: capsules, hard gastro-resistant

ATC: A02BC01

Manufacturer: Teva Pharma S.L.U.

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis (GERD), the eradication of H. pylori bacteria (in combination with antibiotics), as well as for Zollinger-Ellison syndrome.

Form: capsules, hard gastro-resistant

ATC: A02BC01

Manufacturer: TOVA Pharmaceutical Europe S.L. (manufacturer responsible for manufacturing, primary and secondary packaging, quality control and batch release)

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis (acid reflux into the esophagus), the eradication of H. pylori bacteria (in combination with antibiotics), as well as for Zollinger–Ellison syndrome.

Form: capsules, hard gastro-resistant

ATC: A02BC01

Manufacturer: TOVA Pharmaceutical Europe S.L. (manufacturer responsible for manufacturing, primary and secondary packaging, quality control and batch release)

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, symptomatic gastroesophageal reflux disease, and Zollinger–Ellison syndrome. It is also used for the eradication of Helicobacter pylori in combination with antibiotics.

Form: lyophilisate for solution for injection

ATC: A02BC01

Manufacturer: ANFARM HELLAS S.A.

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. It is also used for the eradication of H. pylori bacteria in combination with antibiotics.

Form: powder for injection solution

ATC: A02BC01

Manufacturer: ANFARM HELLAS S.A.

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. It is also used for the eradication of Helicobacter pylori in combination with antibiotics.

Form: lyophilisate for solution for injection

ATC: A02BC01

Manufacturer: Napro Life Sciences Pvt. Ltd

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. It is also used for the eradication of Helicobacter pylori in combination with antibiotics.

Form: powder and solvent for injection solution

ATC: A02BC01

Manufacturer: ANFARM HELLAS S.A.

The drug is used for the treatment and prevention of gastric and duodenal ulcers (including those caused by anti-inflammatory drugs), for the treatment of gastroesophageal reflux disease (reflux esophagitis), for Zollinger–Ellison syndrome, and for the eradication of H. pylori bacteria in combination with antibiotics.

Form: capsules

ATC: A02BC01

Manufacturer: Dr. Reddy's Laboratories Ltd, FTO – II

The drug is used to treat dyspepsia (indigestion) associated with increased gastric acidity, which manifests as heartburn, acid regurgitation, and upper abdominal pain.

Form: capsules

ATC: A02BC01

Manufacturer: Dr. Reddy's Laboratories Ltd, FTO – 3

The drug is used for the treatment and prevention of gastric and duodenal ulcers (including those caused by non-steroidal anti-inflammatory drugs), for the eradication of H. pylori bacteria in combination with antibiotics, for gastroesophageal reflux disease (reflux esophagitis), and Zollinger-Ellison syndrome. In children, it is prescribed for the treatment of reflux esophagitis and heartburn symptoms.

Form: capsules

ATC: A02BC01

Manufacturer: Dr. Reddy's Laboratories Ltd, FTO – 3

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis and gastroesophageal reflux disease. It is also used for the eradication of Helicobacter pylori in combination with antibiotics and in Zollinger-Ellison syndrome.

Form: lyophilisate for solution for injection

ATC: A02BC01

Manufacturer: Napro Life Sciences Pvt. Ltd

The drug is used for the treatment and prevention of gastric and duodenal ulcers, the treatment of reflux esophagitis, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. It is also used for the eradication of Helicobacter pylori in combination with antibiotics and for the prevention of ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs).

Form: powder for solution for infusion

ATC: A02BC01

Manufacturer: Sofarimex – Industria Chimica e Farmaceutica, S.A.

The drug is used for the treatment of gastric and duodenal ulcers, reflux esophagitis, as well as for functional dyspepsia, gastroparesis, and delayed gastric emptying.

Form: capsules, hard

ATC: A02BC

Manufacturer: Torrent Pharmaceuticals Ltd

The drug is used for the short-term treatment of acid-related disorders accompanied by nausea, as well as for the treatment of gastritis or gastroesophageal reflux disease if accompanied by vomiting.

Form: capsules, modified release, hard

ATC: A02X

Manufacturer: Dr. Reddy's Laboratories Ltd, FTO – II

The drug is intended for the eradication (removal) of Helicobacter pylori bacteria in patients with gastric and duodenal ulcers.

Form: tablets, coated and capsules

ATC: A02BD05

Manufacturer: San Pharmaceutical Industries Limited